Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility (Q48431382)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 1985

edit

Language	Label	Description	Also known as
English	Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility	scientific article published in December 1985

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

title

Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

author name string

Michel E

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

Bents H

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

Akhtar FB

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

Hönigl W

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

Knuth UA

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

Sandow J

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

Nieschlag E

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

publication date

1 December 1985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

published in

Clinical Endocrinology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

page(s)

663-675

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

cites work

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1985.TB01127.X

retrieved

21 January 2018

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1985.TB01127.X

retrieved

21 January 2018

Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1985.TB01127.X

retrieved

21 January 2018

Clinical trial with testosterone undecanoate for male fertility control

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1985.TB01127.X

retrieved

21 January 2018

Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1985.TB01127.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2265.1985.TB01127.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

PubMed publication ID

3938352

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3938352

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3938352

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48431382&oldid=2235401148"